MTP915B - Pyrralidine derivatives - Google Patents
Pyrralidine derivativesInfo
- Publication number
- MTP915B MTP915B MT915A MTP915A MTP915B MT P915 B MTP915 B MT P915B MT 915 A MT915 A MT 915A MT P915 A MTP915 A MT P915A MT P915 B MTP915 B MT P915B
- Authority
- MT
- Malta
- Prior art keywords
- formula
- pyrralidine
- derivatives
- hydrogen
- useful
- Prior art date
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- JGPIWNNFLKDTSR-UHFFFAOYSA-N 2-(2-oxopyrrolidin-1-yl)acetic acid Chemical class OC(=O)CN1CCCC1=O JGPIWNNFLKDTSR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 125000001589 carboacyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Peptides Or Proteins (AREA)
- Electronic Switches (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH4849/81A CH647234A5 (en) | 1981-07-24 | 1981-07-24 | Pyrrolidine derivatives |
| CH276882 | 1982-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MTP915B true MTP915B (en) | 1985-12-28 |
Family
ID=25691358
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MT915A MTP915B (en) | 1981-07-24 | 1982-07-20 | Pyrralidine derivatives |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US4476308A (ja) |
| EP (1) | EP0071216B1 (ja) |
| AT (2) | ATE24488T1 (ja) |
| AU (1) | AU557651B2 (ja) |
| BG (1) | BG38334A3 (ja) |
| CA (1) | CA1176251A (ja) |
| CS (1) | CS226746B2 (ja) |
| DD (1) | DD202540A5 (ja) |
| DE (2) | DE3274851D1 (ja) |
| DK (1) | DK157848C (ja) |
| EG (1) | EG15921A (ja) |
| ES (1) | ES8307743A1 (ja) |
| FI (1) | FI75158C (ja) |
| FR (1) | FR2515179A1 (ja) |
| GB (2) | GB2110207B (ja) |
| HK (1) | HK53788A (ja) |
| HU (1) | HU187777B (ja) |
| IE (1) | IE53428B1 (ja) |
| IL (1) | IL66341A (ja) |
| IT (1) | IT1152287B (ja) |
| LU (1) | LU84294A1 (ja) |
| MC (1) | MC1476A1 (ja) |
| MT (1) | MTP915B (ja) |
| NL (1) | NL8202922A (ja) |
| NO (1) | NO159592C (ja) |
| NZ (1) | NZ201297A (ja) |
| OA (1) | OA07151A (ja) |
| PH (1) | PH19149A (ja) |
| PT (1) | PT75314B (ja) |
| RO (1) | RO84097B (ja) |
| SE (1) | SE8204445L (ja) |
| SG (1) | SG22788G (ja) |
| SU (1) | SU1281172A3 (ja) |
| ZW (1) | ZW14482A1 (ja) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2515179A1 (fr) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique |
| IT1206699B (it) * | 1984-02-27 | 1989-04-27 | Isf Spa | Procedimento per preparare derivati di pirrolidone. |
| IT1173763B (it) * | 1984-03-30 | 1987-06-24 | Proter Spa | Derivati dell'acido 3-mercapto-2-oxo-1-pirrolidinacetico,procedimento di preparazione e composizioni farmaceutiche che li contengono |
| IT1190378B (it) * | 1985-06-21 | 1988-02-16 | Isf Spa | Derivati pirrolidonici |
| US4758585A (en) * | 1985-08-16 | 1988-07-19 | Warner-Lambert Company | Saturated cycloalkyl (B) pyrrol-1 (2H)- acetic acid amides and derivatives thereof |
| IT1224168B (it) * | 1986-08-01 | 1990-09-26 | Finanziaria R F Spa Ora Finanz | Derivati del pirrolidin-2-one ad attivita' nootropa |
| CA1322199C (en) * | 1987-07-15 | 1993-09-14 | Masami Eigyo | N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia |
| JPS6422883A (en) * | 1987-07-17 | 1989-01-25 | Sanwa Kagaku Kenkyusho Co | 1-pyrrolidine acetamide derivative, its salt, production thereof and prophylactic and remedial agent for cereral dysfunction containing said derivative and salt as active ingredient |
| DE3813416A1 (de) * | 1988-04-21 | 1989-11-02 | Hoechst Ag | 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte |
| EP0440789A1 (de) * | 1988-04-22 | 1991-08-14 | 2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA | Carbalkoxymethylether von lactam-1-essigsäure sowie herstellungsverfahren |
| IT1245870B (it) * | 1991-06-05 | 1994-10-25 | Sigma Tau Ind Farmaceuti | 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| DE4127404A1 (de) * | 1991-08-19 | 1993-02-25 | Thomae Gmbh Dr K | Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| CA2100641A1 (en) * | 1992-07-23 | 1994-01-24 | Hiromu Matsumura | Novel piperidine derivatives and process for preparation thereof |
| US5679798A (en) * | 1996-11-22 | 1997-10-21 | Mona Industries, Inc. | Silicone monomers having a carboxyl functional group thereon |
| JP2001524071A (ja) * | 1996-11-22 | 2001-11-27 | モナ・インダストリーズ・インコーポレーテッド | カルボキシル官能基を有するシリコーンモノマー及びオリゴマー |
| US6686477B2 (en) | 2000-09-29 | 2004-02-03 | Eastman Chemical Company | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| EP2346500B1 (en) * | 2008-10-16 | 2017-05-17 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| WO2011100373A1 (en) * | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
| JP6433482B2 (ja) | 2013-03-15 | 2018-12-05 | エージンバイオ， インコーポレイテッド | 認知機能を改善するための方法および組成物 |
| WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
| GB1309692A (en) * | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
| IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
| IT1075564B (it) * | 1977-02-11 | 1985-04-22 | Isf Spa | Procedimento per la preparazione di derivati pirrolidinici |
| IT1075280B (it) * | 1977-02-11 | 1985-04-22 | Isf Spa | Procedimento per la preparazione di derivati pirrolidinici |
| BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
| DE2923975A1 (de) * | 1979-06-13 | 1980-12-18 | Nattermann A & Cie | Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel |
| DE2924011C2 (de) * | 1979-06-13 | 1982-04-08 | A. Nattermann & Cie GmbH, 5000 Köln | Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten |
| IT1141287B (it) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
| IT1131959B (it) * | 1979-08-09 | 1986-06-25 | Hoffmann La Roche | Derivati pirrolidinici |
| CH657527A5 (de) * | 1980-02-13 | 1986-09-15 | Ciba Geigy Ag | Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist. |
| US4372960A (en) * | 1980-12-12 | 1983-02-08 | Warner-Lambert Company | Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators |
| CH646149A5 (de) * | 1981-02-05 | 1984-11-15 | Hoffmann La Roche | Pyrrolidin-derivat. |
| FR2515179A1 (fr) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique |
| BE892942A (fr) * | 1982-04-23 | 1982-10-25 | Ucb Sa | Procede pour prevenir ou attenuer les psychoses iatrogenes causees par les medicaments a activite cytostatique. |
-
1982
- 1982-06-22 FR FR8210861A patent/FR2515179A1/fr active Granted
- 1982-06-29 NO NO822222A patent/NO159592C/no unknown
- 1982-07-09 IT IT22335/82A patent/IT1152287B/it active
- 1982-07-09 CA CA000407012A patent/CA1176251A/en not_active Expired
- 1982-07-14 DK DK317382A patent/DK157848C/da not_active IP Right Cessation
- 1982-07-16 ZW ZW144/82A patent/ZW14482A1/xx unknown
- 1982-07-16 IL IL66341A patent/IL66341A/xx unknown
- 1982-07-16 NZ NZ201297A patent/NZ201297A/en unknown
- 1982-07-17 EG EG430/82A patent/EG15921A/xx active
- 1982-07-19 OA OA57742A patent/OA07151A/xx unknown
- 1982-07-19 AU AU86158/82A patent/AU557651B2/en not_active Ceased
- 1982-07-19 RO RO108194A patent/RO84097B/ro unknown
- 1982-07-19 FI FI822543A patent/FI75158C/fi not_active IP Right Cessation
- 1982-07-20 NL NL8202922A patent/NL8202922A/nl not_active Application Discontinuation
- 1982-07-20 MT MT915A patent/MTP915B/xx unknown
- 1982-07-21 HU HU822357A patent/HU187777B/hu not_active IP Right Cessation
- 1982-07-21 DD DD82241833A patent/DD202540A5/de unknown
- 1982-07-21 CS CS825575A patent/CS226746B2/cs unknown
- 1982-07-22 SU SU823466582A patent/SU1281172A3/ru active
- 1982-07-22 MC MC821598A patent/MC1476A1/xx unknown
- 1982-07-23 DE DE8282106690T patent/DE3274851D1/de not_active Expired
- 1982-07-23 PH PH27623A patent/PH19149A/en unknown
- 1982-07-23 GB GB08221446A patent/GB2110207B/en not_active Expired
- 1982-07-23 IE IE1768/82A patent/IE53428B1/en not_active IP Right Cessation
- 1982-07-23 DE DE19823227649 patent/DE3227649A1/de not_active Withdrawn
- 1982-07-23 AT AT82106690T patent/ATE24488T1/de active
- 1982-07-23 ES ES514267A patent/ES8307743A1/es not_active Expired
- 1982-07-23 BG BG057520A patent/BG38334A3/xx unknown
- 1982-07-23 SE SE8204445A patent/SE8204445L/xx not_active Application Discontinuation
- 1982-07-23 PT PT75314A patent/PT75314B/pt unknown
- 1982-07-23 EP EP82106690A patent/EP0071216B1/de not_active Expired
- 1982-07-23 AT AT0286382A patent/AT384424B/de not_active IP Right Cessation
- 1982-07-23 LU LU84294A patent/LU84294A1/de unknown
-
1983
- 1983-06-20 US US06/506,147 patent/US4476308A/en not_active Expired - Fee Related
-
1984
- 1984-06-25 US US06/624,303 patent/US4650878A/en not_active Expired - Fee Related
- 1984-10-16 GB GB08426076A patent/GB2152038B/en not_active Expired
-
1988
- 1988-04-05 SG SG227/88A patent/SG22788G/en unknown
- 1988-07-14 HK HK537/88A patent/HK53788A/xx unknown
-
1990
- 1990-04-12 US US07/508,675 patent/US5034402A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4476308B1 (ja) | ||
| GR3022116T3 (en) | Thiazolidin-2,4-dione derivatives, process for their preparation and pharmaceutical compositions containing them | |
| NZ216048A (en) | Quinolylglycinamide derivatives, and pharmaceutical compositions containing such | |
| ATE18228T1 (de) | Neue thieno-thiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| HUT39147A (en) | Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds | |
| DE3660546D1 (en) | Phosphoroimidates |